antithyroid drugs and liver thyroalex
TRANSCRIPT
![Page 1: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/1.jpg)
Antithyroid drugs and liver
Alaa Wafa. MDAssociate Professor of Internal Medicine
Diabetes and Endocrine unitMansoura university
Thyroalex ( 8 May 2015)
![Page 2: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/2.jpg)
AgendaClinical background
Side effects of antithyroid drugs
Antithyroid induced liver injury
Factors affecting antithyroid induced liver
injury Therpeutic stratigies
agaist antithyroid induced hepatic injury
![Page 3: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/3.jpg)
Anti thyroid drugs
• An antithyroid agent is a hormone antagonist acting upon thyroid hormones.• (also called thionamides) • Mostly used to treat hyperthyroidism caused by Graves' disease.• Antithyroid drugs block the formation , so decrease
the levels of the two hormones produced by the thyroid, thyroxine (T4) and triiodothyronine (T3)
![Page 4: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/4.jpg)
short-term TTT in people with Graves' to prepare for thyroid
surgery or radioiodine.
long-term TTT, approximately 30 % of people with Graves' disease will have a remission after prolonged
TTT with antithyroid drugs.
TTT of hyperthyroidism associated with TMNG or a toxic adenoma
("hot nodule"), usually to prepare for thyroid surgery or radioiodine .
TTT of hyperthyroidism during pregnancy.
Antithyroid drugs may be used as
![Page 5: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/5.jpg)
TYPES OF ANTITHYROID DRUGS
In USA • propylthiouracil (PTU) • methimazole(MMI, Tapazole).
In Europe• propylthiouracil (PTU) • Carbimazole (which is
converted into MMI in the body)
A less common antithyroid agent is potassium perchlorate.
![Page 6: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/6.jpg)
Methimazole
• Reverses hyperthyroidism more quickly than PTU• Fewer side effects. • It requires an average of six weeks to lower
T4 levels to normal • Often given before radioactive iodine
treatment. • Can be taken once per day.
![Page 7: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/7.jpg)
Propylthiouracil
• Does not reverse hyperthyroidism as rapidly as MMI• Has more side effects. • Because of its potential for liver damage,
it is used only when MMI or carbimazole are not appropriate.
• PTU must be taken two to three times per the day.
![Page 8: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/8.jpg)
• The drug of choice during pregnancy• Experts now recommend that PTU be given
during the first trimester only.because there have been rare cases of liver damage in people taking PTU.
• Women who are nursing, methimazole is a better choice than PTU (to avoid liver side effects).
Propylthiouracil
![Page 9: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/9.jpg)
AgendaClinical background
Side effects of antithyroid drugsAntithyroid induced liver
injury Factors affecting
antithyroid induced liver injury
Therpeutic stratigies agaist antithyroid
induced hepatic injury
![Page 10: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/10.jpg)
Side effects of antithyroid drugs
• Mostly are minor, but major side effects can occur.
• No way to predict who will experience side effects
• It is important to discuss all possible side effects before starting treatment.
• If antithyroid treatments cannot be tolerated, we can consider radioiodine treatment or surgery.
![Page 11: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/11.jpg)
• It can occur in up to 15 % of people who take an antithyroid drug in Both MMI and PTU:
itching rash joint pain and swelling fever changes in taste nausea, and vomiting.
Minor side effects
![Page 12: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/12.jpg)
If one drug another causes
side effects drugSwitch to
![Page 13: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/13.jpg)
Fortunately, the major side effects of antithyroid drugs are very rare.
• Agranulocytosis• liver damage• aplastic anemia• vasculitis
Major side effects
![Page 14: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/14.jpg)
Fortunately, the major side effects of antithyroid drugs are very rare.
• Agranulocytosis• liver damage• aplastic anemia• vasculitis
Major side effects
![Page 15: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/15.jpg)
Antithyroid drug
associated liver damage
![Page 16: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/16.jpg)
![Page 17: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/17.jpg)
![Page 18: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/18.jpg)
mechanism of antithyroid drug associated liver
damage
• The mechanism is not clear • this type of drug induced liver injury (DILI) is uncommon• Not obviously related to drug dose• multifactorial dependent • Therefore, these reactions are termed 'idiosyncratic'
DILI (IDILI).
![Page 19: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/19.jpg)
Mechanism of antithyroid drug associated liver
damage
• Despite the great effects of these drugs in controlling hyperthyroidism, their administration is
associated with hepatotoxicity as a serious side effect.
• Hepatic injury induced by these agents could be so severe that might lead to hepatic failure and requirement for liver
transplantation,and even death has been reported in some cases.
![Page 20: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/20.jpg)
PTU associated liver damage
![Page 21: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/21.jpg)
PTU associated liver damagePropylthiouracil was approved for marketing
in 1947. Its frequency is approximately 0.1% based on
the available data. PTU associated liver damage typically occurs
within three months of starting the drug. Patients should be counseled to recognize
and report symptoms suggestive of hepatic dysfunction (especially in first 6 months of treatment), which should prompt immediate discontinuation
![Page 22: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/22.jpg)
• The FDA's Adverse Event Reporting System
A total of 32(22 adult & 10 pediatric) cases of serious liver injury associated with the use of PTU were reported to since that system was established in 1969 through October 2008
Of the 22 adult cases, the FDA identified 12 deaths and five liver transplants.
Of the 10 pediatric cases, there was one death and six reports of liver transplant.
![Page 23: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/23.jpg)
Pathologic findings of PTU-induced hepatic injury in human subjects
Parenchymal necrosis with hemorrhage, Collapse of lobular architecture, Preportal mixed inflammatory infiltrate.
![Page 24: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/24.jpg)
• The pattern of hepatic injury by PTU Hepatocellular type in most cases Hepatic reactions: in the form of hepatitis Severe liver injury (some fatal) acute liver failure (some cases requiring
transplantation) have been reported
![Page 25: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/25.jpg)
Liver transaminase abnormalityo indicate subclinical liver injury which
considered a common event after PTU administration
o incidence with PTU is very high compared with methimazole .
asymptomatic elevation of serum ALT developed in 14.3% of investigated patients in a single center retrospective study.
PTU therapy might be continued with caution in the presence of elevated liver transaminases, without hyperbilirubinemia .
![Page 26: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/26.jpg)
Methimazole induced hepatotoxicity
![Page 27: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/27.jpg)
• Methimazole-induced hepatotoxicity usually develops in the first few weeks of drug consumption with an estimated incidence of 0.1-0.2%.
• The pattern of liver injury induced by methimazole is predominantly as cholestatic type
• Pathhologic findings oedema and inflammation of portal
tract with intracanalicular cholestasis and moderate microvascular steatosis
![Page 28: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/28.jpg)
![Page 29: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/29.jpg)
Carbimazol induced liver damage
![Page 30: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/30.jpg)
Carbimazol induced liver damage
• Hepatic: Hepatic necrosis, hepatitis, jaundice• Hepatic reactions: Rare, severe hepatic
reactions (hepatic necrosis, hepatitis, encephalopathy) may occur; possibly fatal.
• Symptoms suggestive of hepatic dysfunction should prompt evaluation.
• Discontinue in the presence of hepatitis (transaminase >3 times upper limit of normal).
![Page 31: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/31.jpg)
Factors affecting antithyroid drug
Induced liver injury
![Page 32: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/32.jpg)
Factors affecting antithyroid drug
Induced liver injury
Drug metabolism
Immunologic mechanisms
Age Gender
Drug /drug interaction
Underlying disease
![Page 33: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/33.jpg)
Drug metabolism
![Page 34: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/34.jpg)
Metabolism of PTU
• PTU is metabolized by glucuronidation in liver• No PTU-related reactive metabolite(s) has been
suggested yet to induce hepatotoxic reactions. But, it has been founded that myeloperoxidase (MPO)-mediated metabolism of PTU led to a reactive metabolite formation which covalently bounded to leukocytes proteins.
• This reactions might be responsible for agranulocytosis as a deleterious adverse effect of PTU
![Page 35: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/35.jpg)
Metabolism of PTU
• The exact CYP enzyme involved in methimazole and/or PTU metabolism is not characterized yet,
• hence further investigations are required to elucidate the possible role of enzyme variation in the hepatotoxicity induced by these drugs.
• Moreover, future investigations could focus on the possibility of reactive metabolite formation during PTU biotransformation in liver.
![Page 36: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/36.jpg)
Metabolism of methimazole
N-methylthiourea sulfenic acid
Methimazole glyoxal :a reactive compound capable of interacting with different intracellular targets such as proteins
![Page 37: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/37.jpg)
• Sulfenic acids may have a role in methimazole-induced hepatotoxicity.
• N-methylthiourea is proposed to be the main methimazole reactive metabolite responsible for the hepatotoxicity induced by this drug.
• glyoxal also might has an important role in cellular injury induced by methimazole
![Page 38: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/38.jpg)
• As methimazole is suspected to metabolized to reactive intermediate(s) which might involve in the hepatic injury induced by this drug
• polymorphism in drug metabolizing enzymes might has a role in the idiosyncratic nature of the hepatic injury induced by this antithyroid medication.
![Page 39: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/39.jpg)
• As mentioned, glucuronidation is a one of the metabolic pathways for antithyroid drugs (especially PTU) to preparing them for excretion
• The polymorphism in uridine diphosphoglucuronosyl transferase enzymes (UGTs) activity is also identified between human populations.
![Page 40: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/40.jpg)
• Hence, another proposed mechanism for hepatotoxicity induced by antithyroid agents could be attributed to their impaired detoxification process, due to lower activity of UGTs.
• Consequently, some populations might be at a greater risk for these drugs to induce hepatic injury
![Page 41: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/41.jpg)
• Since some investigations mentioned a potential role for "sulfur" atom in antithyroid agents to induce toxicity during metabolism,substituting "sulfur" with "selenium" might reduce the risk of antithyroid drugs-induced liver injury.
• However, the possibility if their serious adverse effects such as hepatotoxicity is lower than conventional drugs, remains to be elucidated in more future investigations
![Page 42: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/42.jpg)
• Some investigations mentioned the critical role of cellular defense mechanisms such as glutathione (GSH) in preventing antithyroid drugs induced hepatotoxicity.
• On the other hand, the liver GSH content might be variable in different situations.
![Page 43: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/43.jpg)
• Hence, particular attention should be given to the possibility that unexpected toxic reactions may be encountered under conditions of tissue GSH depletion.
• Physicians might advise their patient to avoiding alcohol consumption during antithyroid therapy.
![Page 44: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/44.jpg)
Immunological mechanisms
![Page 45: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/45.jpg)
• Immune-mediated reactions are suggested to play a role in antithyroid drug-induced hepatotoxicity. • Although the mechanism(s) underlying this
event is not fully elucidated yet but cytokines are thought to play a role in immunemediated liver injury caused by methimazole.
![Page 46: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/46.jpg)
• The release of cytokines and autoantibodies are reported in antithyroid drugs-treated patients
• Lymphocyte sensitization in a patient with neonatal liver injury probably by placental transfer of PTU has been reported.
All these reports are in line with the hypothesis that patient immune system might play a role in the pathogenesis of hepatic injury induced by antithyroid medications.
![Page 47: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/47.jpg)
• The presence of autoantibodies :- preneuclear antineutrophil cytoplasmic
antibody - antimyeloperoxidase antineutrophil
cytoplasmic antibody All indicate that the immune system might
be involved in antithyroid drugs side effects
![Page 48: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/48.jpg)
• the reactive metabolites of antithyroid agents are capable of interacting with different targets including proteins. Hence, these modified proteins might act as haptens and consequently stimulate the immune system this is called (hapten hypothesis).
![Page 49: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/49.jpg)
Age
![Page 50: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/50.jpg)
• Trials demonestrated that methimazole administration caused less severe hepatotoxic events and vasculitis in children than PTU.
• No reports of liver failure or liver transplantation in association with methimazole use in children in united states. So methimazole is safer in management of
hyperthyroidism in children but this doesn't mean that it is completely safe.
![Page 51: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/51.jpg)
• More serious adverse events reported in FDA database for PTU than methimazole.
• Hence, some investigators suggested that PTU should no longer be used as a first line treatment for Graves' disease in children
![Page 52: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/52.jpg)
In older patients
The average consumption of drugs is higher including ;
*multiple medications *the risk for an additional disease that could influence the manifestation of
idiosyncratic DILI is greater
Mitochondrial function (which is a frequent intracellular target of many drugs) is gradually weakening with advancing age, and cumulative oxidative damage to mitochondria keeps surging.
Thus, oxidative damage to mitochondria is a critical factor of susceptibility.
![Page 53: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/53.jpg)
In older patients
• In addition, the variability in the activity of different enzymes which are responsible for the detoxification process of electrophilic species, namely glutathione transferase enzymes (GSTs), might also be involved in the different responses to antithyroid medications between adults and children.
![Page 54: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/54.jpg)
In older patients
• On the other hand, methimazole should be administered cautiously in older persons with an appropriate dose, not only because of the concern for higher rate of agranulocytosis, but also probably because of more susceptibility of these patients to the hepatic injury induced by this drug.
![Page 55: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/55.jpg)
Gender
![Page 56: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/56.jpg)
• Generally, drugs-induced hepatotoxicity is more prevalent in females.
• A large retrospective study has recognized that 76% of all patients who developed severe liver failure due to drugs were females.
• No clear reason has been identified for this increased susceptibility to many different drugs in women.
![Page 57: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/57.jpg)
• Some authors has found no sex differences related to antithyroids-induced hepatotoxicity
• Hyperthyroidism is more common in women Hence, any probable relationship between patients sex and antithyroid drugs-induced hepatotoxicity might be simply due to the more rate of antithyroid drug prescription in females.
![Page 58: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/58.jpg)
Drug interaction
![Page 59: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/59.jpg)
• Drug-induced hepatotoxicity can be affected by drug interactions.
• Generally, drug interactions occur when two drugs are co-administered and both are metabolized by the same CYP450.
• But, in another situation when a drug toxic metabolite is responsible for hepatotoxic reactions, coadministration of enzyme-inducing agents might deteriorate its hepatotoxic properties.
![Page 60: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/60.jpg)
• other drugs with enzyme-inducing properties such as carbamazepine, isoniazid, etc. might interact with methimazole to lead hepatotoxic reactions
• be cautious about coadministrating the drugs with hepatic enzyme inducing properties, such as phenobarbital, with antithyroid medications.
![Page 61: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/61.jpg)
Underlying disease
![Page 62: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/62.jpg)
• Several different disorders can cause hyperthyroidism.• Graves' disease (GD), is the most common cause of
hyperthyroidism in humans. • Many investigations have been carried out on the
complications which occur in hyperthyroid patients with GD. It has been shown that, the activity of different enzymes which are involved in the antioxidant defense mechanism of liver, are changed in hyperthyroidism.
• Komosinska et al. showed that glutathione reductase (GR) activity, was lower in hyperthyroid patients.
![Page 63: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/63.jpg)
• As antithyroid drugs induced hepatotoxicity is deteriorated in experimental models with defected liver protective mechanisms, the question arises if GD can sensitize individuals to the antithyroid medications' adverse hepatic effects
• The hypothesis that GD itself has a role in antithyroid drugs-induced hepatic injury, needs more controlled and in depth investigations to be clarified.
![Page 64: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/64.jpg)
Therapeutic strategies againstAntithyroid drugs induced
hepatotoxicity
![Page 65: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/65.jpg)
Therpeutic stratigies
• No other medical intervention except for drug cessation and liver function monitoring
• However, intra vascular glutathione was founded to be an effective treatment in a case of methimazole-induced hepatotoxicity
• In another study , corticosteroids might alleviate methimazole induced hepatitis
![Page 66: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/66.jpg)
Therpeutic stratigies
• In experimental models ; organosulfur compounds and the amino acid, taurine, could ameliorate the toxic insult caused by methimazole.
• In another in vivo study, Nacetyl cysteine (NAC) successfully prevented methimazole-induced hepatic injury
These new protective strategies might help to develop a useful hepatoprotective agent against antithyroid drugs-
induced liver injury in humans.
![Page 67: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/67.jpg)
• methimazole and PTU may be associated with the serious side effect of hepatotoxicity.
• Methimazole has been the most prescribed antithyroid drug these years
• methimazole is preferred due to Factors such as higher potency, convenient daily dosing, and the better toxic profile
CONCLUSION
![Page 68: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/68.jpg)
• But, physicians should be aware that methimazole can be associated with hepatotoxicity.
• Patients who take antithyroid drugs should be aware of possible susceptibility factors such as alcohol consumption, which might hasten liver damage induced by antithyroid medications.
CONCLUSION
![Page 69: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/69.jpg)
FDA• An increased risk of liver injury with
propylthiouracil compared to methimazole• Health care professionals should carefully
consider which drug to initiate in a patient recently diagnosed with Graves' disease.
• If propylthiouracil therapy is chosen, the patient should be closely monitored for symptoms and signs of liver injury, especially during the first six months after initiating therapy.
![Page 70: Antithyroid drugs and liver thyroalex](https://reader036.vdocument.in/reader036/viewer/2022070602/587468751a28abab198b74cf/html5/thumbnails/70.jpg)